← back to search

Paul Dark

Manchester Academic Health Science Centre · GB
Area of research
Neurology · Epidemiology
Research interest
Research interests include Sepsis Diagnosis and Treatment, COVID-19 Clinical Research Studies, Traumatic Brain Injury and Neurovascular Disturbances, and Nosocomial Infections in ICU.
h-index
66
citations
18,823
works
372
NIH funding
primary concept
Medicine
email

Recent publications

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2026cited by 3position: contributordoi
Time of day of cardiac surgery and postoperative outcomes in the UK: a secondary analysis of linked national datasets.
2026cited by 2position: contributordoi
Acute breathlessness as a cause of hospitalisation in Malawi: a prospective, patient-centred study to evaluate causes and outcomes.
2026cited by 1position: contributordoi
Ask not for whom the bell tolls: a meditation on the utility of serum creatinine on Critical Care.
2026cited by 0position: contributordoi
Which issues should be addressed in future trials regarding the use of corticosteroids in community acquired pneumonia? A survey of REMAP-CAP investigators.
2026cited by 0position: contributordoi
A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME study.
2026cited by 0position: contributordoi
The effectiveness of decompressive craniectomy size in traumatic brain injury; an international, observational, comparative effectiveness study.
2026cited by 0position: contributordoi
Clinical effectiveness of procalcitonin- or C-reactive protein-guided antibiotic discontinuation protocols for adult patients who are critically ill with sepsis: a rapid systematic review and meta-analysis.
2026cited by 0position: contributordoi
SHORTER trial: protocol for a pragmatic, multicentre, randomised controlled trial of short-duration antibiotic therapy for critically ill patients with sepsis.
2026cited by 0position: contributordoi
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.
2026cited by 0position: contributordoi
Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial.
2025cited by 61position: contributordoi
Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia : The REMAP-CAP Corticosteroid Domain Randomized Clinical Trial.
2025cited by 37position: contributordoi
INHALE WP3, a multicentre, open-label, pragmatic randomised controlled trial assessing the impact of rapid, ICU-based, syndromic PCR, versus standard-of-care on antibiotic stewardship and clinical outcomes in hospital-acquired and ventilator-associated pneumonia.
2025cited by 27position: contributordoi
Dexmedetomidine- or Clonidine-Based Sedation Compared With Propofol in Critically Ill Patients: The A2B Randomized Clinical Trial.
2025cited by 25position: contributordoi
Association of Blood-Based Biomarkers and 6-Month Patient-Reported Outcomes in Patients With Mild TBI: A CENTER-TBI Analysis.
2025cited by 10position: contributordoi
The burden of multimorbidity-associated acute hospital admissions in Malawi and Tanzania: a prospective multicentre cohort study.
2025cited by 5position: contributordoi
Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial.
2025cited by 5position: contributordoi
Prognostic models for depression and post-traumatic stress disorder symptoms following traumatic brain injury: a CENTER-TBI study.
2025cited by 4position: contributordoi
One-year employment outcome prediction after traumatic brain injury: A CENTER-TBI study.
2025cited by 4position: contributordoi
Beyond mild, moderate, and severe traumatic brain injury: modelling severity from clinical, neuroimaging, and blood-based indicators
EBioMedicine 2025cited by 4position: middledoi
TILTomorrow today: dynamic factors predicting changes in intracranial pressure treatment intensity after traumatic brain injury
Scientific Reports 2025cited by 3position: middledoi
Remote multicomponent rehabilitation compared to standard care for survivors of critical illness after hospital discharge (iRehab): a protocol for a randomised controlled assessor-blind clinical and cost-effectiveness trial.
2025cited by 3position: contributordoi
Incidence of diabetes mellitus following hospitalisation for COVID-19 in the United Kingdom: A prospective observational study.
2025cited by 3position: contributordoi
Imaging the microvasculature using nailfold capillaroscopy in patients with coronavirus disease-2019; A cross-sectional study.
2025cited by 2position: contributordoi
Antibiotics for common infections in primary care before, during and after the COVID-19 pandemic: cohort study of extent of prescribing based on risks of infection-related hospital admissions.
2025cited by 2position: contributordoi
The COnfederation of REspiratory Critical Care Trials (CoReCCT): a UK research confederation.
2025cited by 2position: contributordoi
Long term health outcomes in people with diabetes 12 months after hospitalisation with COVID-19 in the UK: a prospective cohort study.
2025cited by 2position: contributordoi
Molnupiravir or nirmatrelvir-ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
2025cited by 2position: contributordoi
Adoption of CKD-EPI (2021) for Glomerular Filtration Rate Estimation: Implications for UK Practice.
2025cited by 1position: contributordoi
Top 10 research priorities for sepsis research determined by patients, carers and clinicians.
2025cited by 1position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

Daniel Kondziella · Columbia University54 papers (2020–2026)Virginia FJ Newcome · University of Pecs51 papers (2020–2025)Alexander Younsi · Institute of Materials, Minerals and Mining51 papers (2020–2025)Juan Sahuquillo · Hebron University49 papers (2020–2025)Rahul Raj · Saveetha University46 papers (2020–2025)Russell L. Gruen · Australian National University41 papers (2020–2025)Antonio Belli · University of Massachusetts Boston37 papers (2021–2025)Guoyi Gao · Capital Medical University35 papers (2020–2024)Vincent Degos · Université Sorbonne Nouvelle31 papers (2020–2022)Endre Czeiter · Addenbrooke's Hospital30 papers (2020–2025)Sandra Rossi · University of Parma27 papers (2020–2022)Renán Sánchez-Porras · Carl von Ossietzky Universität Oldenburg24 papers (2020–2022) · 24 papers (2020–2026)Pedro A. Gómez · Research Institute Hospital 12 de Octubre23 papers (2020–2022)Helen Dawes · University of Exeter22 papers (2021–2025)Matej Oresic · Universitätsklinikum Würzburg21 papers (2021–2025)Marek Majdan · Comenius University Bratislava16 papers (2020–2022)Lindsay Wilson · University of Pecs16 papers (2020–2025)Fiona Elizabeth Lecky · University of Manchester15 papers (2020–2022)Christopher A Green · Johns Hopkins Hospital15 papers (2020–2023)